KAS109

KAS109 Updated 

In @ open with 0.2 % capital at risk. 2 ATR stop($19.65). Breaking thru to the other side, hopefully it will hold. Earnings winner. Dividend payer. Risks: market takes a dive. False Breakout here would mean buy signal next time better odds. Plan B is to re-enter later if it fails here and pivots above $19.33

KAS109 Updated 

Short on TSLA today. Breaking support levels! "Tesla’s earnings were a ‘debacle,’ says longtime bull in scorching commentary" -MarketWatch MarketWatchApril 25, 2019

KAS109 Updated 

Breaking out of the rectangle, also fits the ascending wedge pattern with a break above. Will give it a shot and bet on the trend. Positive earnings. Stop set if it falls back into the consolidation range = trend failed. Wary of extended SP500, but following price as always.

KAS109 Updated 

I am a buyer if it closes above the 5 EMA. Will do a 2ATR stop. Earnings winner. Ascending wedge. HHs, HLs. Piercing $8.71 will give me extra confidence and what I would like to see happen. will place 0.2% of capital at risk as always...

KAS109 Updated 

Two big red candles, double top = selling pressure to the upside, is everyone out yet that wants to be out? that is the question. Short here with 1 ATR stop and a 20% target to the down side.

KAS109 Updated 

Short based on 50% fib retracement and candlestick pattern. Friday is a sell day usually, maybe a pop and drop or just a drop? tomorrow am. $131.74 is stop.TGIF.

KAS109

In at $33.29. 1 ATR stop in place. Target = 20% Bearish engulfing. Biotech sector bearish.

KAS109 Updated 

Price tightening up and wedging. If price trades above $17.42 or new 1 mos. high, I will buy. + dividend. I like the mini double bottom, price rejected below $16.22 . Also some very high volume days, tends to be a runner. Higher lows so far, but no higher high, just waiting.

KAS109

LONG idea. Quiet trend up. Stop = $11.74 In at $12.48

KAS109 Updated 

Stop $20.97 (10% from entry)

KAS109 Updated 

Making new highs and higher lows. Nice consolidation along base. Earnings winner. Moving averages splitting open. MACD up. Double bottom. Volatility factor slightly rising, and quietly trending after earnings. Positive fundamentals. I like so many things about this one! Using 10% stop loss from entry for future to better track my results, which is near swing low...

KAS109 Updated 

I went long on this I think Thurs or Friday. Higher highs and higher lows, nice basing pattern with breakout above triangle. My stop is @ $11.14 (about 10% plus is below swing low). Below $12.03, I would view as negative if it drops back into it's consolidation zone. XOM looking nice today too. I normally avoid ETFs as a general rule, but this ETF fit the pattern.

KAS109 Updated 

Put in a new 7 day high here after consolidating, I will follow price higher. Price bouncing off the 20 EMA. Stop = $12.12 (seems to respect the 50 EMA) BB squeezing together. 0.2% risk on capital From yahoo finance - Evoqua Water Technologies is a leading provider of mission-critical water and wastewater treatment solutions, offering a broad portfolio of...

KAS109 Updated 

Entry = 53.89 Stop Loss = 57.16 New Low today Small share size 0.2% capital risk Using this for a token short, I am 90% LONG this market.

KAS109 Updated 

Buy signal here today, low volatility reading. Uptrend with higher low in place. Stop loss less than 10%, swing low @ $16.70. We can see that the long term downtrend has been broken now. 0.2% capital at risk

KAS109 Updated 

Higher lows, but not higher highs yet. I have an alert set for $5.11 and if it breaks, I will buy. Double bottom pattern in place with nice consolidation. Earnings positive. Actually I may pick up some shares here, but would be pure speculation and outside of strategy. From Yahoo Finance- Feb. 20th SRC Energy (SRCI) came out with quarterly earnings of $0.30 per...

KAS109 Updated 

Watching for a break above $14.75. nice base consolidation here. Former runner. Ascending wedge pattern. 10, 20 and 50 EMA forming a nice floor for a stop loss. See if it holds $14 or not. No position yet. Risk: biotechs normally I avoid, but this has a nice pattern. Also on guard for any overall market weakness which will probably negate this as a potential...

KAS109 Updated 

If this can break through resistance @ $11.35 and resolve the gap @ $12.04, then I would be a buyer. Has support from the 10 and 20 ema, but will it hold? No position here. Any positive news might give it the juice it needs. Risks: Class action lawsuit stagnation From Forbes: David Zalik is the cofounder and CEO of financial technology company GreenSky. The...